Correspondence 0001193125-24-019538 from FRACTYL HEALTH, INC. (GUTS)
FRACTYL HEALTH, INC.
Date: Jan. 30, 2024 · CIK: 0001572616 · Accession: 0001193125-24-019538
AI Filing Summary & Sentiment
File numbers found in text: 333-276046
Letter
Underwriter Acceleration Request
VIA EDGAR
January 30, 2024
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549-6010
Attention:
Tyler Howes
Alan Campbell
Michael Fay
Brian Cascio
Re:
Fractyl Health. Inc. (the “Registrant”)
Registration Statement on Form S-1 (File No. 333-276046)
Request for Acceleration
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), BofA Securities, Inc., Morgan Stanley & Co. LLC and Evercore Group L.L.C., as representatives of the several underwriters, hereby join the Registrant in requesting that the Securities and Exchange Commission take appropriate action to cause the Registration Statement on Form S-1 (File No. 333-276046) (the “Registration Statement”) to become effective as of 4:00 p.m. Eastern time, on February 1, 2024, or as soon thereafter as possible.
Pursuant to Rule 460 of the General Rules and Regulations of the Securities and Exchange Commission under the Securities Act of 1933, as amended, please be advised that there has been distributed or will be distributed to each underwriter or dealer who is reasonably anticipated to participate in the distribution of the security as many copies of the Company’s preliminary prospectus dated January 29, 2024, as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
We advise that we have complied and will continue to comply, and that we have been informed by the participating underwriters that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, to the extent applicable.
[signature page follows]
Very truly yours,
BOFA SECURITIES, INC.
Show Raw Text
CORRESP 1 filename1.htm Underwriter Acceleration Request VIA EDGAR January 30, 2024 United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549-6010 Attention: Tyler Howes Alan Campbell Michael Fay Brian Cascio Re: Fractyl Health. Inc. (the “Registrant”) Registration Statement on Form S-1 (File No. 333-276046) Request for Acceleration Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), BofA Securities, Inc., Morgan Stanley & Co. LLC and Evercore Group L.L.C., as representatives of the several underwriters, hereby join the Registrant in requesting that the Securities and Exchange Commission take appropriate action to cause the Registration Statement on Form S-1 (File No. 333-276046) (the “Registration Statement”) to become effective as of 4:00 p.m. Eastern time, on February 1, 2024, or as soon thereafter as possible. Pursuant to Rule 460 of the General Rules and Regulations of the Securities and Exchange Commission under the Securities Act of 1933, as amended, please be advised that there has been distributed or will be distributed to each underwriter or dealer who is reasonably anticipated to participate in the distribution of the security as many copies of the Company’s preliminary prospectus dated January 29, 2024, as appears to be reasonable to secure adequate distribution of the preliminary prospectus. We advise that we have complied and will continue to comply, and that we have been informed by the participating underwriters that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended, to the extent applicable. [signature page follows] Very truly yours, BOFA SECURITIES, INC. MORGAN STANLEY & CO. LLC EVERCORE GROUP L.L.C. As representatives of the Underwriters BOFA SECURITIES, INC. By: /s/ Michele A.H. Allong Name: Michele A.H. Allong Title: Authorized Signatory MORGAN STANLEY & CO. LLC By: /s/ Chris Rigoli Name: Chris Rigoli Title: Executive Director EVERCORE GROUP L.L.C. By: /s/ Ed Baxter Name: Ed Baxter Title: Senior Managing Director [Signature Page to Acceleration Request Letter]